Refametinib (R enantiomer)
Based on 1 publication(s) in Google Scholar
Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC50 of 2.0-15 nM.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 923032-38-6
- Fòrmula: C19H20F3IN2O5S
- Peso molecular:572.34
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Refametinib (R enantiomer)
MoreVer todos los productos específicos de isoformas MEK
More
Actividad biológica
Descripciòn
IC50 & Target
[1]|
MEK 2-15 nM (EC50) |
In Vitro
Refametinib R enantiomer is the R enantiomer of Refametinib . Refametinib R enantiomer is an inhibitor of MEK and is useful in treatment of cancer and other hyperproliferative diseases[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 923032-38-6
-
Peso molecular 572.34
-
Fòrmula C19H20F3IN2O5S
-
SMILES
O=S(C1(C[C@H](CO)O)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
-
Synonyms
BAY 869766 R enantiomer; RDEA119 R enantiomer
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Sci Adv
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS. [Abstract]2019 Aug 14;5(8):eaav8463. PMID: 31453322
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)